chronic-obstructive

Documents about chronic-obstructive

• Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD)#867983ClinicalTrials.gov
• Pulmonary Rehabilitation During Acute Exacerbations of Chronic Obstructive Pulmonary Disease: a Mixed-methods Approach#868389ClinicalTrials.gov
• Adherence to Medication and Its Impact on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: The AMICE Prospective Study#872469ClinicalTrials.gov
• High Frequency Chest Wall Oscillation in Chronic Obstructive Pulmonary Disease (COPD)#883036ClinicalTrials.gov
• Single Dose Study to Assess Efficacy and Safety of 4 Doses of LAS100977 in Chronic Obstructive Pulmonary Disease (COPD) Population#885315ClinicalTrials.gov
• Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease#889560ClinicalTrials.gov
• Rehabilitation of Patients With Lung Chronic Obstructive Pulmonary Disease#894816ClinicalTrials.gov
• Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype#876692ClinicalTrials.gov
• ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.#862326ClinicalTrials.gov
• ICS/LABA Adherence and COPD Exacerbation#898043ClinicalTrials.gov
• Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease#913021ClinicalTrials.gov
• Epidemiology of Airway Responsiveness#917239ClinicalTrials.gov
• Comparison Between Sit-to-stand Test and Six-minute Walk Test in Chronic Obstructive Pulmonary Disease#801858ClinicalTrials.gov
• Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal#806338ClinicalTrials.gov
• Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease#845283ClinicalTrials.gov
• Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients#863740ClinicalTrials.gov
• Prevalence and Clinical Outcome of Eosinophilic COPD#863823ClinicalTrials.gov
• Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients#878608ClinicalTrials.gov
• Effects of Kinesiotaping Technique on Lung Function & Functional Capacity of Chronic Obstructive Lung Disease Patients#880227ClinicalTrials.gov
• Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients#889178ClinicalTrials.gov
• The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute Exacerbation#907494ClinicalTrials.gov
• Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis#916227ClinicalTrials.gov
• A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)#803735ClinicalTrials.gov
• High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease#830181ClinicalTrials.gov
• Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)#843025ClinicalTrials.gov
• Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)#844054ClinicalTrials.gov
• IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study#869681ClinicalTrials.gov
• A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease#871565ClinicalTrials.gov
• Neuromuscular Fatigue in Chronic Obstructive Pulonary Disease#872916ClinicalTrials.gov
• Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America#901026ClinicalTrials.gov
• Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)#904241ClinicalTrials.gov
• Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD)#907872ClinicalTrials.gov
• Cohort Study of Airway Microecology and the Pathogenesis and Evolution of Chronic Obstructive Pulmonary Disease#917208ClinicalTrials.gov
• Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial#628560ClinicalTrials.gov
• Nocturnal Oxygen Therapy#846922ClinicalTrials.gov
• Home Non Invasive Ventilation (NIV) Treatment for COPD-patients After a NIV-treated Exacerbation#833622ClinicalTrials.gov
• Macrolide Maintenance Therapy in Chronic Obstructive Pulmonary Disease#640433ClinicalTrials.gov
• SPIRIVA in Ususal Care#800728ClinicalTrials.gov
• Tiotropium (Spiriva) Rehabilitation Study#869572ClinicalTrials.gov
• Cardiac Hemodynamics in Overlap Syndrome (COPD With Obstructive Sleep Apnea)#855473ClinicalTrials.gov
• Association Between Handgrip Strength and Small Airway Disease in Patients with Stable Chronic Obstructive Pulmonary Disease#828159ClinicalTrials.gov
• Physical Capacity of Patients With Chronic Obstructive Pulmonary Disease With and Without Supplementation of Whey#833436ClinicalTrials.gov
• Mindful-Breath for People With COPD#858476ClinicalTrials.gov
• Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI#876147ClinicalTrials.gov
• A Randomised Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Chronic Obstructive Pulmonary Disease (COPD)#881035ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease#882961ClinicalTrials.gov
• Withdrawal of Non-invasive Ventilation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Acute Hypercapnic Respiratory Failure#913708ClinicalTrials.gov
• Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)#853294ClinicalTrials.gov
• Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period#863253ClinicalTrials.gov
• A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)#896495ClinicalTrials.gov